102 related articles for article (PubMed ID: 15552614)
1. Unilateral trichomegaly induced by bimatoprost ophthalmic solution.
Hempstead N; Hempstead RW
J Drugs Dermatol; 2004; 3(5):571-2. PubMed ID: 15552614
[TBL] [Abstract][Full Text] [Related]
2. Acquired trichomegaly of the eyelashes and hypertrichosis induced by bimatoprost.
Herane MI; Urbina F
J Eur Acad Dermatol Venereol; 2004 Sep; 18(5):644-5. PubMed ID: 15324422
[No Abstract] [Full Text] [Related]
3. Instilled bimatoprost ophthalmic solution in patients with eyelash alopecia areata.
Ochoa BE; Sah D; Wang G; Stamper R; Price VH
J Am Acad Dermatol; 2009 Sep; 61(3):530-2. PubMed ID: 19700021
[No Abstract] [Full Text] [Related]
4. Hypertrichosis of vellus hairs of the malar region after unilateral treatment with bimatoprost.
Hart J; Shafranov G
Am J Ophthalmol; 2004 Apr; 137(4):756-7. PubMed ID: 15059720
[TBL] [Abstract][Full Text] [Related]
5. Latisse: empirical discovery yields treatment for sparse eyelashes.
Woodson SA
Nurs Womens Health; 2009 Jun; 13(3):243-8. PubMed ID: 19523139
[No Abstract] [Full Text] [Related]
6. Enhancing the growth of natural eyelashes: the mechanism of bimatoprost-induced eyelash growth.
Cohen JL
Dermatol Surg; 2010 Sep; 36(9):1361-71. PubMed ID: 20384750
[TBL] [Abstract][Full Text] [Related]
7. Prevention of dermatologic side effects of bimatoprost 0.03% topical therapy.
Centofanti M; Oddone F; Chimenti S; Tanga L; Citarella L; Manni G
Am J Ophthalmol; 2006 Dec; 142(6):1059-60. PubMed ID: 17157592
[TBL] [Abstract][Full Text] [Related]
8. Hypertrichosis of the eyelashes caused by bimatoprost.
Tosti A; Pazzaglia M; Voudouris S; Tosti G
J Am Acad Dermatol; 2004 Nov; 51(5 Suppl):S149-50. PubMed ID: 15577756
[TBL] [Abstract][Full Text] [Related]
9. Latisse (bimatoprost) for enhancement of eyelashes.
Flaharty PM; Flaharty KK; Gorman L
Insight; 2014; 39(3):24-6. PubMed ID: 25195339
[No Abstract] [Full Text] [Related]
10. Lack of efficacy of topical latanoprost and bimatoprost ophthalmic solutions in promoting eyelash growth in patients with alopecia areata.
Roseborough I; Lee H; Chwalek J; Stamper RL; Price VH
J Am Acad Dermatol; 2009 Apr; 60(4):705-6. PubMed ID: 19293023
[No Abstract] [Full Text] [Related]
11. Application of bimatoprost ophthalmic solution 0.03% for the treatment of eyebrow hypotrichosis: series of ten cases.
Vergilis-Kalner IJ
Dermatol Online J; 2014 Jun; 20(6):. PubMed ID: 24945645
[TBL] [Abstract][Full Text] [Related]
12. Latisse-induced periocular skin hyperpigmentation.
Priluck JC; Fu S
Arch Ophthalmol; 2010 Jun; 128(6):792-3. PubMed ID: 20547960
[No Abstract] [Full Text] [Related]
13. Characterization of an in vivo model for the study of eyelash biology and trichomegaly: mouse eyelash morphology, development, growth cycle, and anagen prolongation by bimatoprost.
Tauchi M; Fuchs TA; Kellenberger AJ; Woodward DF; Paus R; Lütjen-Drecoll E
Br J Dermatol; 2010 Jun; 162(6):1186-97. PubMed ID: 20346040
[TBL] [Abstract][Full Text] [Related]
14. Bimatoprost 0.03% solution (latisse) for eyelash enhancement.
Med Lett Drugs Ther; 2009 Jun; 51(1313):43-4. PubMed ID: 19478690
[No Abstract] [Full Text] [Related]
15. Clinical management of trichotillomania with bimatoprost.
Peabody T; Reitz S; Smith J; Teti B
Optom Vis Sci; 2013 Jun; 90(6):e167-71. PubMed ID: 23645373
[TBL] [Abstract][Full Text] [Related]
16. Corneal sensitivity changes following the instillation of latanoprost, bimatoprost, and travoprost eyedrops.
Kozobolis VP; Detorakis ET; Maskaleris G; Koukoula SC; Fountoulakis N; Chrysochoou F; Konstas AG
Am J Ophthalmol; 2005 Apr; 139(4):742-3. PubMed ID: 15808188
[TBL] [Abstract][Full Text] [Related]
17. Patient-reported outcomes of bimatoprost for eyelash growth: results from a randomized, double-masked, vehicle-controlled, parallel-group study.
Fagien S; Walt JG; Carruthers J; Cox SE; Wirta D; Weng E; Beddingfield FC
Aesthet Surg J; 2013 Aug; 33(6):789-98. PubMed ID: 23873891
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of bimatoprost for the treatment of open-angle glaucoma and ocular hypertension: a three-month, open-label study in community-based practices in Thailand.
Wanichwecha-Rungruang B; Iemsomboon W
J Med Assoc Thai; 2005 Sep; 88(9):1228-35. PubMed ID: 16536109
[TBL] [Abstract][Full Text] [Related]
19. Ocular effects of topical 0.03% bimatoprost solution in normotensive feline eyes.
Regnier A; Lemagne C; Ponchet A; Cazalot G; Concordet D; Gelatt KN
Vet Ophthalmol; 2006; 9(1):39-43. PubMed ID: 16409244
[TBL] [Abstract][Full Text] [Related]
20. Successful use of bimatoprost in the treatment of alopecia of the eyelashes.
Zaheri S; Hughes B
Clin Exp Dermatol; 2010 Jun; 35(4):e161-2. PubMed ID: 19925481
[No Abstract] [Full Text] [Related]
[Next] [New Search]
